FDA Advances Real-Time Clinical Trials: What It Means for AI-Driven Drug Development

For 60 years, clinical trial data has moved on a one-way delay: sites collect it, sponsors analyze it, and only then does it reach the FDA, sometimes years after a safety signal first appeared. On April 28, 2026, the FDA (Food & Drug Administration) announced two major steps toward advancing its initiative on FDA real-time […] The post FDA Advances Real-Time Clinical Trials: What It Means for AI-Driven Drug Development appeared first on Saama .